A new ligand H4Lox and its iron(III) complex as a platform for the development of heterotrimetallic complexes

Cobalt(III)-py2en systems as potential carriers of β-ketoester-based ligands

Two cobalt(III) complexes containing different β-ketoesters, namely [CoIII(L1)(py2en)](ClO4)2·H2O (1) and [CoIII(L2)(py2en)](ClO4)2 (2) (py2en = N,N'-bis(pyridin-2-ylmethyl)ethylenediamine; L1- = methylacetoacetate; L2- = ethyl 4-chloroacetoacetate) have been prepared and investigated as prototypes of bioreductive prodrugs. The presence of β-ketoester and py2en ligands in 1 and 2, as well as the perchlorate counterions, was supported by IR spectroscopy and CHN elemental analysis. The composition molecular structure of both complexes was confirmed by NMR spectroscopy and ESI mass spectrometry. Structural information was also obtained for 2via X-ray diffraction analysis. The redox properties indicate that 1 and 2 are suitable for reduction under biological conditions. Investigation of DNA-interacting suggest that 1 and 2 bind DNA via electrostatic forces. Both complexes may be employed as possible platforms for the delivery of biologically active compounds, since their reaction with ascorbic acid in PBS at pH 6.2 and 7.4 at 37°C results in the release of the β-ketoester ligands upon Co(III)/Co(II) reduction.

Investigation of cobalt(III)-phenylalanine complexes for hypoxia-activated drug delivery

Four cobalt(iii)-phenylalanine complexes, [Co(Phe)(py2en)](ClO4)2·H2O (1), [Co(Phe)(TPA)](ClO4)2·H2O (2), [Co(Phe)(py2enMe2)](ClO4)2·H2O (3) and [Co(bipy)2(Phe)](ClO4)2·H2O (4), were investigated as prototype models for hypoxia-activated delivery of melphalan - a phenylalanine derivative anticancer drug of the class of nitrogen mustards. Single crystal X-ray diffraction analysis provided the molecular structures of 1-4, as a single isomer/conformer. According with NMR and theoretical calculations, the solid-state structures of 2 and 4 are maintained in solutions. For complexes 1 and 3, though, a mixture of isomers was found in DMSO solutions: Λ-cisα(exo,exo) and Δ-cisβ1(exo,exo) for 1 (3 : 2 ratio), and Λ-cisα(exo,exo) and Δ-cisα(exo,exo) for 3 (5 : 1 ratio). Theoretical calculations point to a re-equilibration reaction of the solid-state Λ-cisβ1 isomer of 1 in solution. Electrochemical analysis revealed a correlation between the electron-donor capacity of the ancillary ligands and the redox potentials of the complexes. The potentials varied from +0.01 for 1 to +0.31 V vs. SHE for 4 in aqueous media and indicate that reduction should be achieved in biological media. The integrity of the complexes in pH 5.5 and 7.4 buffered solutions was confirmed by UV-Vis monitoring up to 24 h at 25 °C. Reduction by ascorbic acid (AA) shows an O2-dependent dissociation of the l-Phe for complexes 1-3, with higher conversion rates at pH 7.4. For complex 4, a fast dissociation of l-Phe was observed, with conversion rates unaffected by the pH and presence of O2.

Solvent responses and substituent effects upon magnetic properties of mononuclear DyIII compounds

Solvent responsive magnets comprise a class of molecule-based materials where lattice solvent driven structural transformation leads to the switching of magnetic properties. Herein, we present a special type of magnet where single-crystal to single-crystal (SCSC) transformations within mononuclear DyIII compounds result in the switching of DyIII single-molecule magnets (SMMs). This structural transformation involves lattice solvents which leads to significant changes in the color and magnetic properties. Additionally, the relaxation dynamics of mononuclear DyIII compounds are perceptibly fine-tuned by the modification of β-diketonate ligands. The uniaxial magnetic anisotropies, magneto-structural correlations and the relaxation mechanism were investigated by magnetic studies and ab initio calculations. These experimental and theoretical studies indicate that compound 2 exhibits the best magnetic properties in compounds 1-4. The experimental observation is supported by the theoretical prediction of QTM time (τZeeQTM) as theτZeeQTM of 2 is remarkably longer than those of the other three compounds by an order of magnitude. This means that, compared with 1, 3, and 4, the magnetic relaxation of 2 is significantly slower. Meanwhile, 2 has the largest value of axial ESP (the axial electrostatic potential), which supports the smallest gXY value in these compounds, resulting in better SMM properties. The present results offer a systematic synthesis regulation to change the magnetization dynamics and further understand magneto-structural correlations for DyIII SMMs.

In Situ Ligand Formation in the Synthetic Processes from Mononuclear Dy(III) Compounds to Binuclear Dy(III) Compounds: Synthesis, Structure, Magnetic Behavior, and Theoretical Analysis

Guided by the self-assembled process and mechanism, the strategy of in situ Schiff base reaction would be capable of bringing a feasible method to construct and synthesize lanthanide compounds with distinct structures and magnetic properties. A mononuclear Dy(III) compound was synthesized through a multidentate Schiff base ligand and a chelating β-diketonate ligand, which was named as [Dy(L)(bppd)]·CH₃OH [1; H₂L = N,N'-bis(2-hydroxy-5-methyl-3-formylbenzyl)-N,N'-bis(pyridin-2-ylmethyl)ethylenediamine and bppd = 3-bis(pyridin-2-yl)propane-1,3-dione]. Furthermore, a new binuclear Dy(III) compound, [Dy₂(H₂Lox)(bppd)₃]·8CH₃OH [2; H₄Lox = N,N'-bis[2-hydroxy-5-methyl-3-(hydroxyiminomethyl)benzyl]-N,N'-bis(pyridin-2-ylmethyl)ethylenediamine], was obtained via an in situ synthetic process. Under similar synthetic conditions, [Dy(L)(ctbd)] [3; ctbd = 1-(4-chlorophenyl)-4,4,4-trifluoro-1,3-butanedione] and [Dy₂(H₂Lox)(ctbd)₃]·CH₃OH·C₄H₁₀O (4) were synthesized by modifying the β-diketonate ligand and in situ Schiff base reaction. Compound 3 is a mononuclear configuration, while compound 4 exhibits a binuclear Dy(III) unit. Therein, formylbenzyl groups of H₂L in 1 and 3 were changed to (hydroxyiminomethyl)benzyl groups in 2 and 4, respectively. In isomorphous 2 and 4, two Dy(III) centers are connected through two phenol O^- atoms of the H₂Lox^2- ligand to form a binuclear structure. Eight-coordinated Dy(III) ions with different distortions can be observed in 1-4. The crystals of 1 and 3 suffered dissolution/precipitation to obtain 2 and 4, respectively. The relationship between the structure and magnetism in compounds 1-4 was discussed through the combination of structural, experimental, and theoretical investigations. Especially, the rates of quantum tunneling of magnetization of 1-4 were theoretically predicted and are consistent with the experimental results. For 2 and 4, the theoretically calculated dipolar parameters J_dip are consistent with the experimental observation of weak ferromagnetic coupling.

Evaluation of cobalt(III) complexes as potential hypoxia-responsive carriers of esculetin

Differentiation between hypoxic and normoxic tissues have been exploited for the development of selective chemotherapeutic agents. In this context, cobalt(III)-based coordination compounds have been designed and investigated as prospective hypoxia-responsive drug delivery systems. Three cobalt(III) complexes, namely [Co^III(esc)(py₂en)]ClO₄·(CH₃OH)₂ (1) [Co^III(esc)(TPA)]ClO₄·3H₂O (2) and [Co^III(bipy)₂(esc)]ClO₄·2.5H₂O (3) (py₂en = N,N'-bis(pyridin-2-ylmethyl)ethylenediamine, TPA = tris(2-pyridylmethyl)amine, bipy = 2,2'-bipyridine and esc = 6,7-dihydroxycoumarin or esculetin), were prepared and investigated as potential carriers of esculetin. The spectroscopic and electrochemical properties of 1-3 were investigated and compared. Reactions of the complexes with biologically relevant reducing agents, viz. ascorbic acid, cysteine and glutathione, were monitored spectroscopically for 24 h, in pH 6.2 and 7.4 PBS phosphate buffer saline (PBS) solutions at 37 °C, under air, argon and dioxygen atmospheres. Dissociation of esculetin was observed upon Co³⁺/Co²⁺ reduction preferably under hypoxic conditions, with more effective conversion rates for 3 > 2 > 1. These results illustrate the importance to modulate the Co³⁺/Co²⁺ redox potential through the donor-acceptor properties of the ancillary ligands. Complex 3 is cytotoxic against HCT-116 but not against HT-29 and HEK-293 cells. In addition, DNA-binding studies indicate that interactions of 1 and 3 with the biomolecule are electrostatic.

Rare CH3O−/CH3CH2O−-bridged nine-coordinated binuclear DyIII single-molecule magnets (SMMs) significantly regulate and enhance the effective energy barriers

This work presents an efficient approach to regulating and enhancing the magnetic anisotropy barriers through using bridged CH₃O⁻ anion or CH₃CH₂O⁻ anion and constructing triple bridges.

Effect of ligand substituents on nickel and copper [N4] complexes: electronic and redox behavior, and reactivity towards protons

The ligand substituents have a major effect on the redox potentials, catalytic efficiency and robustness of the complexes in HER.

Ligand ratio/solvent-influenced syntheses, crystal structures, and magnetic properties of polydentate Schiff base ligand-Dy(iii) compounds with β-diketonate ligands as co-ligands

Tuning the synthesis conditions and further regulating the magnetic dynamics of single-molecule magnets (SMMs) are crucial challenges for chemists.

Investigation of cobalt(iii)–TPA complexes as potential bioreductively activated carriers for naphthoquinone-based drugs

Differently from CH₃, halogens as substituents foster incorporation of methoxide into NQs upon complexation.